Epithelial-Mesenchymal Transition

Epithelial-mesenchymal transition (EMT) is a process whereby largely adherent and polarized epithelial cells acquire the phenotype of more mobile mesenchymal cells. EMT not only facilitates morphogenesis during embryonic development but also promotes invasion and metastasis in tumors. Pathological EMT is associated with E-cadherin repression, which has been shown to contribute to tumor progression. Several oncogenic pathways (e.g., TGF-beta, Wnt/beta-catenin, integrins, and Notch) have been reported to induce EMT via cytoskeleton rearrangement and activation of E-cadherin repressors, including Snail, Slug, SIP1, ZEB1, and TCF3.

 

EMT-inducing Transcription Factors

 
   
beta Catenin antibody

beta Catenin antibody
(GTX101435)

Citation SupportKOKD Validation
SNAI1 antibody

SNAI1 antibody
(GTX100754)

Citation SupportOrthogonal Validation
Twist1/2 antibody

Twist1/2 antibody
(GTX127310)

Citation SupportOrthogonal ValidationProtein Overexpression
 

 

Epithelial Markers

 
    
E-Cadherin antibody

E-Cadherin antibody
(GTX100443)

Citation SupportKOKD ValidationOrthogonal Validation
Cytokeratin 8 antibody

Cytokeratin 8 antibody
(GTX112975)

Citation SupportKOKD Validation
Cytokeratin 18 antibody

Cytokeratin 18 antibody
(GTX112978)

Citation SupportKOKD Validation
 

 

Mesenchymal Markers

 
   
alpha Smooth Muscle Actin antibody

alpha Smooth Muscle Actin antibody
(GTX100034)

Citation SupportKOKD ValidationOrthogonal Validation
Fibronectin antibody

Fibronectin antibody
(GTX112794)

Citation SupportKOKD ValidationOrthogonal Validation
N-Cadherin antibody

N-Cadherin antibody
(GTX127345)

Citation SupportKOKD ValidationOrthogonal Validation